Skip to content

A study of the factors affecting the dose of the pain medication (fentanyl) used for treating pain after surgery in South Indian population.

Pharmacogenetics of intravenous fentanyl for postoperative analgesia in South Indian population.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019588
Enrollment
257
Registered
2019-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 - 70 years. 2. Patients of female sex. 3. Patients of South Indian origin defined by history of belonging to any of the South Indian states, namely, Tamil Nadu, Kerala, Karnataka, Andhra Pradesh, Telangana and Pondicherry and having one of the South Indian languages as their mother tongue for 3 consecutive generations. 4. Patients undergoing major breast surgeries under general anaesthesia categorized as American Society of Anaesthesiology classification (ASA) I-III. (a measure of physical status of the patient). 5. Patients requiring postoperative intravenous fentanyl through Patient controlled Analgesia (PCA) pump.

Exclusion criteria

Exclusion criteria: 1. Pregnant patients and lactating mothers. 2. Patients with evidence of any Hepatic impairment (hepatic enzymes - SGOT or SGPT more than 3 times the upper limit of normal range) or Renal impairment (Creatinine clearance less than 90 ml/min as calculated by Cockroft - Gault equation). 3. Patients with continuous epidural analgesia in the postoperative period. 4. Patients on mechanical ventilation for more than 4 hours in the postoperative period. 5. Patients with peripheral neuropathy 6. Patients with localized skin lesions over the cubital fossa 7. Patients with history of any addiction to opioids or other narcotics. 8. Patients with history of use of any known inducers or inhibitors of CYP3A4 enzyme within 5 days of the study period (including alcohol, grape fruit juice, drugs like phenytoin, ketoconazole, etc).

Design outcomes

Primary

MeasureTime frame
Association between genetic markers and the total intravenous fentanyl dose for postoperative analgesiaTimepoint: 24 hours postoperative dose of fentanyl

Secondary

MeasureTime frame
Association between genetic markers and cold pain toleranceTimepoint: preoperative period;Association between genetic markers and pupil response to intravenous fentanylTimepoint: 10 minutes after administering intravenous fentanyl for induction of anaesthesia;Association between genetic markers and the plasma norfentanyl/fentanyl ratioTimepoint: 30 minutes after administering intravenous fentanyl for induction of anaesthesia

Countries

India

Contacts

Public ContactDr R Kesavan

Jawaharlal Institute of Post-graduate Medical Education and Research (JIPMER)

kes7ramasamy@gmail.com9360532592

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026